The Pentagon has walked back a controversial directive that would have required mandatory testosterone deficiency screening for male active-duty and reserve service members aged 30 and older, according to a Pentagon official. The guidance, which was initially unveiled just the day before its rescission, would have mandated testosterone blood tests for men over 30 while applying different standards to younger service members. The rapid reversal has raised questions about the policy's development process and the broader implications for military medical screening protocols. The episode underscores ongoing tensions within the Department of Defense over how to balance health monitoring with the practical realities of managing a large, diverse force.
The Pentagon temporarily rescinded the recently issued guidance instructing mandatory testosterone deficiency screening for male active-duty and reserve service members age 30 and older, a Pentagon official told The Hill on Thursday. The guidance, which was unveiled on Wednesday, stated that men over the age of 30 would get testosterone blood tests, while those younger...
